• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Meta­bol­ic dis­ease out­fit ac­cus­es Chi­nese biotech of steal­ing trade se­crets to ad­vance com­pet­ing drug

3 years ago
Pharma
Law

Jan­u­ary’s new drug price in­creas­es take off with­out over­com­pen­sat­ing for up­com­ing in­fla­tion-linked re­bates

3 years ago
Pharma

Fed­er­al court deals blow to Gilead and Astel­las in patent case against Pfiz­er gener­ic

3 years ago
Pharma
Law

Sesen Bio push­es back af­ter in­vestor group at­tacks merg­er as ‘il­log­i­cal’

3 years ago
Financing
Deals

FDA pol­i­cy change opens the door for abor­tion pill in phar­ma­cies

3 years ago
Pharma

Af­ter three-decade jour­ney, Geron sees new life in PhI­II da­ta on MDS drug, plots path to ap­proval

3 years ago
R&D

'Sor­ry, Es­cape Bio closed': A neu­rode­gen­er­a­tive up­start ex­its bid to ri­val Bio­gen-De­nali

3 years ago
Startups

Ful­crum CEO leaves for new op­por­tu­ni­ty, com­pa­ny starts search for re­place­ment

3 years ago
People

Hum­ming­bird and Synaf­fix agree to an­ti­body-drug con­ju­gate deal worth up to $150M

3 years ago
Deals
R&D

Scoop: MPM backs a new check­point in­hibitor biotech in $80M raise

3 years ago
Financing
Startups

Vi­vid­ion 2.0? Ben Cra­vatt and Scripps team form a new chemo­pro­teomics biotech

3 years ago
Financing
Startups

Cap­si­da makes $55M deal with Eli Lil­ly to de­vel­op gene ther­a­pies

3 years ago
Deals
R&D

FDA de­ci­sion, launch of gas­troin­testi­nal drug de­layed af­ter ni­trosamine found in com­mer­cial batch­es

3 years ago
FDA+

Mod­er­na's glo­be­trot­ting BD team snags an mR­NA up­start with some handy new tech tools

3 years ago
Deals

De­ci­phera re­vives hopes for Qin­lock with sub­group analy­sis, plots new PhI­II — but mar­ket re­ac­tion is mut­ed

3 years ago
R&D

Roivan­t's ul­cer­a­tive col­i­tis drug from Pfiz­er shows promis­ing da­ta in ear­ly read­out

3 years ago
R&D

Ve­ra Ther­a­peu­tics sprints to PhI­II with treat­ment for rare kid­ney dis­ease

3 years ago
R&D

Athenex to ex­it drug com­pound­ing busi­ness and axe 92 em­ploy­ees at NY plant

3 years ago
Pharma
Manufacturing

CMS needs to strength­en its in­ter­nal con­trols to en­sure Part B drug pay­ment ac­cu­ra­cy, OIG finds

3 years ago
Pharma

Up­dat­ed: Drug­mak­ers ben­e­fit 'sub­stan­tial­ly' from sec­ondary patents on in­halers — study

3 years ago
Pharma
FDA+

Am­gen files brief to Supreme Court ahead of oral ar­gu­ments — with in­dus­try am­i­cus sup­port

3 years ago
Pharma
Law

Pas­sage of FDA Mod­ern­iza­tion Act 2.0 clears the way to re­duce an­i­mal test­ing

3 years ago
R&D
Pharma

Sen­ate Fi­nance Chair Wyden con­tin­ues fight over low phar­ma tax rates, this time with BMS

3 years ago
Pharma

Ab­b­Vie 'Dis­cov­ery Files' do­cuseries de­tails the ori­gin sto­ries of med­i­cines

3 years ago
Pharma
Marketing
First page Previous page 396397398399400401402 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.